Ortho-Clinical launches new lab systems in EU
Ortho Clinical Diagnostics, a division of US health care giant Johnson & Johnson, has launched two new clinical laboratory systems, the Vitros 5600 Integrated System and Vitros 3600 Immunodiagnostic System, in Europe.
The firm says the compact systems do not have any water or drainage requirements, making the most of limited lab space while allowing flexibility in instrument location.
"Our mission has always been to give health professionals the highest quality tools to determine the best treatment," said David Atkins, Vice President for Ortho Clinical Diagnostics, Europe, Middle East and Africa. "The introduction of the Vitros 5600 Integrated System and Vitros 3600 Immunodiagnostic System continues this mission with next generation instruments that have a broad, world-class menu of assays and the capacity to support future high-impact tests," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze